Jane Street Group, LLC Aim Immuno Tech Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.4 - $0.56 $3,026 - $4,236	7,565 Added 55.25%	21,257 $9,000
Q3 2023 Nov 14, 2023	SELL	$0.44 - $0.71 $3,718 - $6,000	-8,452 Reduced 38.17%	13,692 $6,000
Q2 2023 Aug 14, 2023	BUY	$0.4 - $0.67 $8,857 - $14,836	22,144 New	22,144 $14,000
Q2 2022 Aug 16, 2022	BUY	$0.78 - $1.27 $8,108 - $13,202	10,396 New	10,396 $8,000
Q1 2022 May 17, 2022	SELL	$0.67 - $1.18 $10,384 - $18,288	-15,499 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.92 - $1.96 $14,259 - $30,378	15,499 New	15,499 $14,000
Q2 2020 Aug 17, 2020	SELL	$1.9 - $2.94 $53,243 - $82,387	-28,023 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.56 - $6.1 $15,692 - $170,940	28,023 New	28,023 $72,000

8.44M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $12M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.